Back to Superinvestors
SUPERINVESTOR HOLDERS
PTGX
Protagonist Therapeutics Inc
Healthcare · Biotechnology
- Holders
- 6
- Total value
- $898,621,750
- Total shares
- 7,330,900
- Cross-link
- Financials →
| Investor | Shares | Value | % of Portfolio | Activity | As of |
|---|---|---|---|---|---|
|
Tom Steyer
Farallon Capital Management LLC
|
6,348,906 | $778,248,897 | 3.61% | HOLD | 30 Jun 2026 |
|
Hersh Cohen
ClearBridge Investments
|
725,335 | $88,911,554 | 0.07% | ADD +103,515 | 30 Jun 2026 |
|
Stanley Druckenmiller
Duquesne Family Office
|
208,900 | $25,607,000 | 0.49% | ADD +49,200 | 30 Jun 2026 |
|
Joel Greenblatt
Gotham Asset Management
|
18,663 | $2,287,711 | 0.01% | REDUCE -2,492 | 30 Jun 2026 |
|
Ron Baron
Baron Capital (BAMCO)
|
16,000 | $1,961,280 | 0.00% | ADD +1,000 | 30 Jun 2026 |
|
Cliff Asness
AQR Capital Management
|
13,096 | $1,605,308 | 0.00% | ADD +1,222 | 30 Jun 2026 |